MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on August 22, 2007; DOI: 10.1124/mol.107.039305


0026-895X/07/7205-1349-1358$20.00
Mol Pharmacol 72:1349-1358, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.039305v1
72/5/1349    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qu, X.
Right arrow Articles by Earnest, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qu, X.
Right arrow Articles by Earnest, D. J.

Disruption of Clock Gene Expression Alters Responses of the Aryl Hydrocarbon Receptor Signaling Pathway in the Mouse Mammary Gland

Xiaoyu Qu, Richard P. Metz, Weston W. Porter, Vincent M. Cassone, and David J. Earnest

Department of Biology and Center for Research on Biological Clocks, College Station, Texas (X.Q., V.M.C., D.J.E.); Department of Integrative Biosciences, College of Veterinary Medicine, Texas A&M University, College Station, Texas (R.P.M., W.W.P.); and Department of Neurosciences and Experimental Therapeutics, Texas A&M University Health Science Center, College of Medicine, College Station, Texas (D.J.E.)

The biological effects of many environmental toxins are mediated by genes containing Per-Arnt-Sim (PAS) domains, the aryl hydrocarbon receptor (AhR), and AhR nuclear translocator. Because these transcription factors interact with other PAS genes that form the circadian clockworks in mammals, we determined whether targeted disruption of the clock genes, Per1 and/or Per2, alters toxin-induced expression of known biological markers in the AhR signaling pathway. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), a prototypical Ahr agonist, had an inductive effect on mammary gland expression of cytochrome P450, subfamily I, polypeptide 1 (Cyp1A1) mRNA regardless of genotype. However, TCDD-mediated Cyp1A1 induction in the mammary glands of Per1ldc and Per1ldc/Per2ldc mice was significantly (17.9- and 5.9-fold) greater than that in wild-type (WT) animals. In addition, TCDD-induced Cyp1B1 expression in Per1ldc and Per1ldc/Per2ldc mammary glands was significantly increased relative to that in WT mice. Similar to in vivo observations, experiments using primary cultures of mammary gland tissue demonstrated that TCDD-induced Cyp1A1 and Cyp1B1 expression in Per1ldc and Per1ldc/Per2ldc mutant cells was significantly greater than that in WT cultures. AhR mRNA levels were distinctively elevated in cells derived from all mutant genotypes, but they were commonly decreased in WT and mutant cultures after TCDD treatment. In WT mice, an interesting corollary is that the inductive effects of TCDD on mammary gland expression of Cyp1A1 and Cyp1B1 vary over time and are significantly greater during the night. These findings suggest that clock genes, especially Per1, may be involved in TCDD activation of AhR signaling pathways.


Received June 27, 2007; accepted August 22, 2007

Address correspondence to: Dr. David J. Earnest, Department of Neuroscience and Experimental Therapeutics, 238 Reynolds Medical Bldg., Texas A&M University Health Science Center, College Station, TX 77843-1114. E-mail: dearnest{at}tamu.edu




This article has been cited by other articles:


Home page
J Biol RhythmsHome page
M. Mukai, T.-M. Lin, R. E. Peterson, P. S. Cooke, and S. A. Tischkau
Behavioral Rhythmicity of Mice Lacking AhR and Attenuation of Light-Induced Phase Shift by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin
J Biol Rhythms, June 1, 2008; 23(3): 200 - 210.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics